Capricor Therapeutics Inc. (CAPR)
NASDAQ · Healthcare
Capricor Therapeutics Inc. Operating Income 2011–2025
Capricor Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Capricor Therapeutics Inc. operating income for the quarter ending September 30, 2024 was -13.0 M, a 89.52% increase year-over-year.
- Capricor Therapeutics Inc. operating income for the twelve months ending September 30, 2024 was -41.7 M, a 51.79% increase year-over-year.
- Capricor Therapeutics Inc. annual operating income for 2025 was -108.1 M, a 154.07% increase from 2024.
- Capricor Therapeutics Inc. annual operating income for 2024 was -42.6 M, a 76.77% increase from 2023.
- Capricor Therapeutics Inc. annual operating income for 2023 was -24.1 M, a 18.92% decrease from 2022.
- Capricor Therapeutics Inc. annual operating income for 2022 was -29.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Capricor Therapeutics Inc. Operating Income — FAQ
Capricor Therapeutics Inc. (CAPR) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Capricor Therapeutics Inc.'s operating income?
Capricor Therapeutics Inc. (CAPR) reported operating income of -$108M for fiscal 2025.
Where can I see CAPR's operating income history?
The chart and table above show Capricor Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.